RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
National Research Stock

National Research Revenue 2024

National Research Revenue

148.58 M USD

Ticker

NRC

ISIN

US6373722023

WKN

A1WYXP

In 2024, National Research's sales reached 148.58 M USD, a -1.99% difference from the 151.6 M USD sales recorded in the previous year.

The National Research Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2023148.5862,30
2022151.662,34
202114864,59
2020133.363,09
201912863,67
2018119.760,23
2017117.658,25
2016109.458,32
2015102.356,40
201498.857,79
201392.657,99
201286.459,03
201175.862,14
201063.461,20
200957.758,06
20085153,73
200748.955,42
200643.855,48
200532.458,02
200429.756,57

National Research Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into National Research, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by National Research from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects National Research’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of National Research. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into National Research’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing National Research’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on National Research’s growth potential.

National Research Revenue, EBIT and net profit per share

DateNational Research RevenueNational Research EBITNational Research Net Income
2023148.58 M undefined40.09 M undefined30.96 M undefined
2022151.6 M undefined60.5 M undefined31.8 M undefined
2021148 M undefined50.5 M undefined37.4 M undefined
2020133.3 M undefined42.2 M undefined37.2 M undefined
2019128 M undefined43 M undefined32.3 M undefined
2018119.7 M undefined35.3 M undefined29.9 M undefined
2017117.6 M undefined34.2 M undefined22.8 M undefined
2016109.4 M undefined31.2 M undefined20.3 M undefined
2015102.3 M undefined26.4 M undefined17.5 M undefined
201498.8 M undefined28.3 M undefined18.2 M undefined
201392.6 M undefined24.8 M undefined15.5 M undefined
201286.4 M undefined22.7 M undefined15.1 M undefined
201175.8 M undefined18.7 M undefined11.6 M undefined
201063.4 M undefined14.6 M undefined8.5 M undefined
200957.7 M undefined13.7 M undefined8.5 M undefined
200851 M undefined12 M undefined7.4 M undefined
200748.9 M undefined11.4 M undefined6.8 M undefined
200643.8 M undefined9.9 M undefined5.9 M undefined
200532.4 M undefined8.4 M undefined5.2 M undefined
200429.7 M undefined7.4 M undefined4.6 M undefined

National Research stock margins

The National Research margin analysis displays the gross margin, EBIT margin, as well as the profit margin of National Research. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for National Research.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the National Research's sales revenue. A higher gross margin percentage indicates that the National Research retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the National Research's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the National Research's total revenue generated. When comparing the revenue margin year over year, investors can gauge the National Research's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the National Research. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the National Research's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

National Research Margin History

National Research Gross marginNational Research Profit marginNational Research EBIT marginNational Research Profit margin
202362.3 %26.98 %20.84 %
202262.34 %39.91 %20.98 %
202164.59 %34.12 %25.27 %
202063.09 %31.66 %27.91 %
201963.67 %33.59 %25.23 %
201860.23 %29.49 %24.98 %
201758.25 %29.08 %19.39 %
201658.32 %28.52 %18.56 %
201556.4 %25.81 %17.11 %
201457.79 %28.64 %18.42 %
201357.99 %26.78 %16.74 %
201259.03 %26.27 %17.48 %
201162.14 %24.67 %15.3 %
201061.2 %23.03 %13.41 %
200958.06 %23.74 %14.73 %
200853.73 %23.53 %14.51 %
200755.42 %23.31 %13.91 %
200655.48 %22.6 %13.47 %
200558.02 %25.93 %16.05 %
200456.57 %24.92 %15.49 %

National Research Aktienanalyse

What does National Research do?

The National Research Corporation (NRC) was founded in 1981 and is headquartered in Lincoln, Nebraska, USA. Since its inception, the company has specialized in researching customer opinions and experiences in the healthcare industry and is therefore one of the leading providers in this market. The NRC's business model consists of helping hospitals, nursing homes, and other healthcare facilities better understand and respond to the needs of their patients and employees. Over the years, the National Research Corporation has continuously expanded its range of services. The company now has several divisions, including: - NRC Health: This is NRC's main business area, which focuses on collecting, analyzing, and reporting customer opinions and experiences in the healthcare industry. NRC Health offers various survey and analysis methods to improve the quality of healthcare and increase customer satisfaction. - Transparency Solutions: This division of NRC Health focuses on creating transparency reports and performance comparisons of medical facilities. These reports are helpful for potential patients and their families to make informed decisions about which medical facilities offer the best treatment. - My InnerView: This is an NRC Health platform specifically designed for long-term care facilities. My InnerView offers survey and analysis methods to improve the quality of care and support for residents in nursing homes. - Market Insights: This division of NRC provides healthcare facilities with access to key information about employee hiring and retention, as well as market trends and competitive analysis. - Resident & Family Experience: This division of NRC focuses on capturing customer feedback and experiences in independent and assisted living facilities. By using surveys and feedback analysis, the company can improve resident and family satisfaction and optimize the customer experience in these facilities. In addition to these various divisions, NRC also offers a variety of products to help healthcare facilities improve their customer and employee experiences. These include survey tools, data analysis software, dashboards, and reporting tools. Overall, over the years, the National Research Corporation has built a strong reputation by helping customers in the healthcare industry better understand and respond to the needs of their patients and employees. The company has established itself as a trusted partner that provides valuable insights into healthcare and supports healthcare facilities in improving customer and employee satisfaction. National Research ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding National Research's Sales Figures

The sales figures of National Research originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing National Research’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize National Research's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in National Research’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about National Research stock

How much revenue did National Research generate this year?

National Research has achieved a revenue of 148.58 M USD this year.

How much was the turnover of the company National Research compared to the previous year?

The revenue of National Research has increased by -1.99% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of National Research?

The revenue of National Research is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of National Research measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of National Research so important for investors?

The revenue of National Research is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does National Research pay?

Over the past 12 months, National Research paid a dividend of 1.48 USD . This corresponds to a dividend yield of about 7.41 %. For the coming 12 months, National Research is expected to pay a dividend of 1.48 USD.

What is the dividend yield of National Research?

The current dividend yield of National Research is 7.41 %.

When does National Research pay dividends?

National Research pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of National Research?

National Research paid dividends every year for the past 19 years.

What is the dividend of National Research?

For the upcoming 12 months, dividends amounting to 1.48 USD are expected. This corresponds to a dividend yield of 7.41 %.

In which sector is National Research located?

National Research is assigned to the 'Health' sector.

Wann musste ich die Aktien von National Research kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of National Research from 10/11/2024 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did National Research pay the last dividend?

The last dividend was paid out on 10/11/2024.

What was the dividend of National Research in the year 2023?

In the year 2023, National Research distributed 0.84 USD as dividends.

In which currency does National Research pay out the dividend?

The dividends of National Research are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von National Research

Our stock analysis for National Research Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of National Research Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.